CA2235264A1 - Chiral methylphenyloxazolidinones - Google Patents

Chiral methylphenyloxazolidinones

Info

Publication number
CA2235264A1
CA2235264A1 CA002235264A CA2235264A CA2235264A1 CA 2235264 A1 CA2235264 A1 CA 2235264A1 CA 002235264 A CA002235264 A CA 002235264A CA 2235264 A CA2235264 A CA 2235264A CA 2235264 A1 CA2235264 A1 CA 2235264A1
Authority
CA
Canada
Prior art keywords
methylphenyloxazolidinones
chiral
formula
drugs
atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002235264A
Other languages
French (fr)
Other versions
CA2235264C (en
Inventor
Henry Laurent
Eckhard Ottow
Gerald Kirsch
Helmut Wachtel
Herbert Schneider
Daryl Faulds
Harald Dinter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19540475A external-priority patent/DE19540475A1/en
Application filed by Individual filed Critical Individual
Publication of CA2235264A1 publication Critical patent/CA2235264A1/en
Application granted granted Critical
Publication of CA2235264C publication Critical patent/CA2235264C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The invention relates to (R)-(-)- methyl phenyl oxazolidinone derivatives of formula (I), and the preparation and use thereof in drugs, formula in which R is a hydrocarbon radical with up to 5 C-atoms.
CA002235264A 1995-10-20 1996-02-09 Chiral methylphenyloxazolidinones Expired - Fee Related CA2235264C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19540475A DE19540475A1 (en) 1995-10-20 1995-10-20 Chiral methylphenyloxazolidinones
DE19540475.0 1995-10-20
PCT/DE1996/000259 WO1997015561A1 (en) 1995-10-20 1996-02-09 Chiral methyl phenyl oxazolidinones

Publications (2)

Publication Number Publication Date
CA2235264A1 true CA2235264A1 (en) 1997-05-01
CA2235264C CA2235264C (en) 2006-11-07

Family

ID=29403426

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002235264A Expired - Fee Related CA2235264C (en) 1995-10-20 1996-02-09 Chiral methylphenyloxazolidinones

Country Status (1)

Country Link
CA (1) CA2235264C (en)

Also Published As

Publication number Publication date
CA2235264C (en) 2006-11-07

Similar Documents

Publication Publication Date Title
CA2354023A1 (en) Phenylglycine derivatives
CA2201812A1 (en) 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses
NZ301645A (en) (R)-(-)-methyl phenyl oxazolidinone derivatives, pharmaceutical preparations and use for treating TNF stimulated diseases
AU5529786A (en) Novel 1,2-benzisoxazol-3-YL and 1,2-benzisothiazol-3-YL derivatives
HK1026909A1 (en) Substituted phenyl derivatives, their preparation and use
CA2150123A1 (en) Aminomethylene substituted non-aromatic heterocycles
AU3074289A (en) 2,2'-iminobisethanol derivatives as potentiators of the effects of blood pressure reducing agents
EP0930309A4 (en) Taxane derivatives and drugs containing the same
CA2156078A1 (en) New imidazopyridines
AU5383390A (en) Laparoscopy cannula
EP0359225A3 (en) Reagents for the preparation of 5'-tagged oligonucleotides
CA2204626A1 (en) Hydrocarbyl containing coatings, compositions and methods of use
AU5485698A (en) Oxyiminopregnancarbolactone
IE870772L (en) Steroids
CA2194885A1 (en) Substituted benzamidines, their preparation and their use as pharmaceutical compounds
CA2183315A1 (en) Novel Mercaptoacetylamido 1,3,4,5-Tetrahydro-Benzo[c]azepin-3-One Disulfide Derivatives Useful as Inhibitors of Enkephalinase and Ace
EP0743311A4 (en) Flavanonol derivatives and hair nourishment and growth stimulant composition containing the same
AU3481289A (en) Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-thia- analogs of 8-substituted-guanine-9-(1'beta-d-aldoglycosidyl) derivatives, compositions and methods
CA2245267A1 (en) Crystal form of n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
CA2038848A1 (en) Hydantoin derivatives
CA2138289A1 (en) N-substituted azabicycloheptane derivatives, the preparation and use thereof
CA2181665A1 (en) Synergistic stabilizer mixture
AU6663496A (en) One pot synthesis of 2-oxazolidinone derivatives
CA2306782A1 (en) Isoquinolines as urokinase inhibitors
CA2241014A1 (en) Morphine derivatives with analgesic activity

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20100209